logo

ORGO

OrganogenesisยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ORGO Profile

Organogenesis Holdings Inc.

A leading regenerative medicine company that offers a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics

Biological Technology
--
12/05/2016
NASDAQ Stock Exchange
869
12-31
Common stock
85 Dan Road , Canton, MA 02021
--
Organogenesis Holdings Inc. is a Delaware corporation. The Company is a leading regenerative medicine company providing a portfolio of bioactive and non-cellular biomaterials in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis' comprehensive product portfolio is designed to treat a variety of patients with repair and regeneration needs.